EC Number |
Reference |
---|
2.3.1.286 | recombinant sirtuin 1 comprising residues 140747 is crystallized using the hanging-drop vapour diffusion method. The crystal diffracted to 3.4 A resolution and belong to space group P622, with unit-cell parameters a = b = 203.1, c = 625.3 A , and is estimated to contain between six and 12 molecules per asymmetric unit |
718508 |
2.3.1.286 | hanging drop vapor diffusion using a 1:1 drop ratio. The 2.5 A crystal structure of the SIRT1 catalytic domain bound to NAD+ and 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide (EX527) |
730166 |
2.3.1.286 | Sirt2 is crystallized in complex with the product analog, ADP-ribose, and this crystal structure is solved at 2.3 A resolution |
730287 |
2.3.1.286 | crystal structure of Sirt3 in complex with fluor-de-Lys peptide and resveratrol and crystal structure of Sirt3 in complex with fluor-de-Lys peptide and piceatannol |
730713 |
2.3.1.286 | crystallization at 4°C by the sitting-drop vapor diffusion method. Crystal structure of human SIRT2 in complex with a macrocyclic peptide inhibitor S2iL5, at 2.5 A resolution |
730980 |
2.3.1.286 | in complex with ADP ribose, microseed matrix seeding, using 17.5% (w/v) PEG 10000, 0.1 M ammonium acetate in 0.1 M bis-Tris buffer pH 6.8 at 20°C |
737389 |
2.3.1.286 | in complex with ADP ribose, microseed matrix seeding, using 25% (w/v) PEG 3350, 0.2 M MgCl2 in 0.1 M bis-Tris buffer pH 5.5 |
737389 |
2.3.1.286 | in complex with BHJH-TM1 protein, hanging drop vapor diffusion method, using 25% (w/v) PEG 3350, 0.1 M HEPES buffer, pH 7.5 |
739668 |
2.3.1.286 | in complex with [histone H3]-N6-myristoyl-L-lysine9, hanging drop vapor diffusion method, using 16% (w/v) PEG 3350, 0.1 M NaF, 7% (v/v) formamide |
749470 |
2.3.1.286 | isoform SIR2-Af1 in complex with NAD+, hanging drop vapor diffusion method, using 100 mM MES (pH 6.0), and 12% (w/v) PEG-10K |
750253 |